These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 25302830

  • 1. Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis.
    Hirooka M, Koizumi Y, Miyake T, Ochi H, Tokumoto Y, Tada F, Matsuura B, Abe M, Hiasa Y.
    Radiology; 2015 Feb; 274(2):597-604. PubMed ID: 25302830
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
    Tana C, Tana M, Rossi S, Silingardi M, Schiavone C.
    J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis.
    Cengiz M, Ozenirler S, Kocabiyik M.
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):57-63. PubMed ID: 26513612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A.
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
    Yilmaz Y, Senates E, Yesil A, Ergelen R, Colak Y.
    J Diabetes Complications; 2014 May; 28(3):328-31. PubMed ID: 24602757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations.
    Dubois A, Dauzat M, Pignodel C, Pomier-Layrargues G, Marty-Double C, Lopez FM, Janbon C.
    Hepatology; 1993 Feb; 17(2):246-50. PubMed ID: 8428721
    [Abstract] [Full Text] [Related]

  • 13. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index.
    Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, Peeters F, ter Beek LC, Horsmans Y, Van Beers BE.
    Radiology; 2007 Nov; 245(2):458-66. PubMed ID: 17940304
    [Abstract] [Full Text] [Related]

  • 14. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M.
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [Abstract] [Full Text] [Related]

  • 15. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.
    Baffy G.
    Dig Dis Sci; 2018 Mar; 63(3):563-576. PubMed ID: 29368124
    [Abstract] [Full Text] [Related]

  • 16. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M, Sacerdoti D, Merkel C, Gerunda G, Maffei-Faccioli A, Angeli P, Jemmolo RM, Bombonato G, Gatta A.
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.
    Mann JP, De Vito R, Mosca A, Alisi A, Armstrong MJ, Raponi M, Baumann U, Nobili V.
    Hepatology; 2016 Mar; 63(3):745-53. PubMed ID: 26638195
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Non-invasive assessment of portal hypertension in patients with liver cirrhosis using FibroScan transient elastography].
    Liu F, Li TH, Han T, Xiang HL, Zhang HS.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):840-4. PubMed ID: 24331694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.